Page 443 - The Vasculitides, Volume 1: General Considerations and Systemic Vasculitis

Index 417

106, 109, 110, 111, 112, 113, 114, 115, 117, 118, thrombin, 381
119, 123, 182, 191, 216, 274, 312 thrombocytopenia, 164, 287, 324
Sweden, 66, 67, 69, 70, 71, 73, 77, 79, 81, 82, 264, thrombocytopenic purpura, 56, 164, 246
299, 300, 301, 343, 361 thrombocytosis, 162, 164, 304, 318, 329, 344, 362
swelling, 20, 34, 35, 36, 42, 285, 319, 320, 340, 345, thrombomodulin, 184, 381
346, 357, 362, 363, 369, 374, 375, 376 thrombophlebitis, 249, 253, 384, 391
symptomatic treatment, 25, 233 thrombosis, 9, 27, 28, 33, 54, 55, 119, 129, 137, 168,
synovial tissue, 298
synovitis, 234, 297, 299 184, 212, 241, 242, 249, 252, 291, 298, 316, 341,
synthesis, 49, 156 344, 349, 352, 355, 362, 366, 389
syphilis, 8, 17, 36, 37, 45, 57, 58 thrombus, 44, 165
systemic lupus erythematosus, 9, 17, 47, 54, 55, 56, thymus, 46, 101
101, 122, 140, 182, 248, 258, 264, 272, 295, 373, thyroid, 233, 234
388, 392, 394, 396 thyroid cancer, 233, 234
systemic sclerosis, 62, 258, 264 thyroiditis, 233, 236
systolic blood pressure, 280, 341 tinnitus, 27, 356
TLR, 75, 87, 88, 101, 313
T TLR2, 106
TLR3, 100
T cell(s), 48, 61, 69, 80, 93, 97, 99, 101, 103, 105, TLR4, 98, 106, 120, 314
106, 108, 111, 151, 187, 191, 196, 197, 273 TLR9, 106
TNF, 33, 47, 48, 57, 61, 62, 90, 98, 100, 106, 111,
T lymphocytes, 126, 128, 196, 273 115, 118, 171, 183, 202, 264, 274, 282, 284, 305,
Taiwan, 73, 74, 75, 82 308, 314, 324, 345, 390
target, vii, 57, 92, 101, 134, 135, 157, 158, 165, 183, TNF-alpha, 61, 111, 115, 118, 274, 308
TNF-?, 183, 390
202, 213, 266, 314, 372, 379 tobacco, 165
targeted therapies, vii tooth, 315
T-cell receptor, 69, 97, 182 toxic side effect, 47
TCR, 97 toxicity, 19, 33, 45, 48, 170, 233, 241, 242, 245
teams, vii toxicology, 266
techniques, 21, 167, 171, 282, 318, 325 toxin, 192
technology, 156 trachea, 149, 180, 253
telangiectasia, 389 tracheostomy, 180, 242
TEM, 187 trade, 321
temperature, 28, 272 trafficking, 75
tempo, 31 transcription, 69, 74, 102, 111, 182, 186, 191
temporal arteritis, 7, 9, 12, 18, 44, 78, 79, 108, 126, transducer, 74, 101
transformation, 238, 374
141, 256, 257, 283, 293, 327, 328, 329, 330, 331, transforming growth factor, 106, 116, 118, 166
333, 334, 335 transfusion, 201
temporal lobe, 33 transient ischemic attack, 316
tension, 315 translation, 10, 186, 273
territory, 36 transmission, 171, 203
tertiary syphilis, 124, 164 transplant, 49, 373
testing, 21, 24, 123, 153, 154, 156, 157, 158, 162, transport, 275
193, 203, 268, 324, 380 transverse section, 319
testis, 298, 386 trauma, 4, 7, 9, 201, 249
tetrad, 287 tremor, 26
TGF, 166, 265 trial, 24, 46, 51, 53, 61, 62, 86, 88, 123, 171, 189,
Th cells, 187 217, 224, 225, 253, 259, 269, 270, 295, 306, 309,
therapeutic agents, 46 312, 332, 333, 334
therapeutic targets, 85 triggers, 69, 86, 101, 161, 182, 264, 273
therapeutic use, 197 tropism, 85
thinning, 348
thoracentesis, 246

Complimentary Contributor Copy